Direct nose to brain delivery of small molecules: critical analysis of data from a standardized in vivo screening model in rats
Open Access
- 1 January 2020
- journal article
- research article
- Published by Taylor & Francis in Drug Delivery
- Vol. 27 (1) , 1597-1607
Abstract
The blood–brain barrier (BBB) is often a limiting factor for getting drugs in the brain. Bypassing the BBB by intranasal (IN), or also called nose to brain (NTB), route is an interesting and frequently investigated concept for brain drug delivery. However, despite the body of evidence for IN drug delivery in literature over the last decades, reproducibility and interpretation of animal data remain challenging. The objective of this project was to assess the feasibility and value of a standardized IN screening model in rats for the evaluation of direct brain delivery. A chemically diverse set of commercial and internal small molecules were tested in the in vivo model with different doses and/or formulations. Data were analyzed using different ways of ratio calculations: blood concentration at time of sacrifice, total exposure in blood (area under the curve, AUC) and the brain or olfactory bulb concentrations. The IN route was compared to another parenteral route to decide if there is potential direct brain transport. The results show that blood and tissue concentrations and ratios are highly variable and not always reproducible. Potential direct brain delivery was concluded for some compounds, however, sometimes depending on the analysis: using blood levels at sacrifice or AUC could lead to different conclusions. We conclude that a screening model for the evaluation of direct brain transport of small molecules is very difficult to achieve and a conclusion based on a limited number of animals with this variability is questionable.Keywords
This publication has 28 references indexed in Scilit:
- Intranasal delivery to the central nervous system: Mechanisms and experimental considerationsJournal of Pharmaceutical Sciences, 2010
- Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative diseaseBMC Neuroscience, 2008
- Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectivesAdvanced Drug Delivery Reviews, 2005
- Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodentsEuropean Journal of Pharmaceutical Sciences, 2005
- Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brainInternational Journal of Pharmaceutics, 2004
- Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to ratsInternational Journal of Pharmaceutics, 2003
- Drug Transport into the Mammalian Brain: The Nasal Pathway and its Specific Metabolic BarrierJournal of Drug Targeting, 2002
- Chromatographic Hydrophobicity Index by Fast-Gradient RP-HPLC: A High-Throughput Alternative to log P/log DAnalytical Chemistry, 1997
- Quantitative analysis of the olfactory pathway for drug delivery to the brainBrain Research, 1995
- Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkeyJournal of Comparative Neurology, 1986